Faruqi & Faruqi Urges LifeMD Investors to Act Before Class Action Deadline

LifeMD Class Action Alert: Important Investor Reminder

Faruqi & Faruqi, LLP, a prominent national securities law firm, has issued a reminder to investors of LifeMD, Inc. regarding a significant class action lawsuit. The deadline for appointing a lead plaintiff in this case is fast approaching—set for October 27, 2025. This prompt serves to inform investors who may have suffered substantial financial losses during the specified period to act quickly and assert their rights.

Understanding the Context

The firm is currently examining claims against LifeMD, Inc. (NASDAQ: LFMD) amid allegations of violations of federal securities laws. Reportedly, the issues stem from misleading statements and an insufficient disclosure of critical business information made by the Company and its executives. These alleged misdeeds include overstated competitive positioning and unrealistic financial guidance that did not appropriately factor in escalating customer acquisition costs.

On August 5, 2025, LifeMD's quarterly financial results shocked investors. The company adjusted its revenue forecast downwards, revealing expectations between $250 million and $255 million, significantly lower than the earlier guidance of $268 million to $275 million. Following this disclosure, the company's stock saw a staggering 44.8% decline the next day, resulting in substantial losses for investors.

Legal Recourse for Affected Investors

Faruqi & Faruqi is extending an invitation to investors who sustained losses exceeding $75,000 between May 7, 2025, and August 5, 2025. If you believe you are eligible, you are urged to reach out to Josh Wilson, a senior partner at the firm. Engaging with the firm can provide you options on how to potentially recover your losses through this class action.

Potential lead plaintiffs play a pivotal role in class action lawsuits. Essentially, they represent the interests of the affected investors in court. Those interested in stepping forward can contact the firm to learn about the process of establishing this pivotal role or can choose to remain an absent class member, which will not hinder their ability to share in any financial recovery from the lawsuit.

Your Next Steps

For anyone with additional information related to LifeMD's conduct or the circumstances leading to their investment losses, Faruqi & Faruqi encourages contact. This includes whistleblowers, former employees, shareholders, and others who might have insight into the case.

For more details on pursuing claims, you can visit Faruqi & Faruqi's LifeMD page or get in touch with Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310). The firm remains committed to upholding the rights of investors and ensuring that those impacted have their voices heard in a court of law.

This situation serves as a crucial reminder for investors regarding the risks in the securities market and the importance of due diligence before making investment decisions. As the lead plaintiff deadline approaches, prompt action may prove invaluable.